OpenVSafe by OpenVAERS
Search V-safe

3WU-18356-20110

2 vaccinations 10 coded responses 25 check-ins 10 free-text entries 2 call cases
Sex
Female
Age at first dose
66+
ZIP prefix
605 / IL
Registered
2021-02-12
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-12
    Registered in v-safe
  2. 2021-02-12
    Dose 1 — Moderna
  3. 2021-02-12
    Health check-in — day 0, dose 1
    Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness · Be unable to work
    Adult check-in
  4. 2021-02-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-02-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-02-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-02-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-02-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-02-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-02-19
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-03-05
    Survey response — day 21, dose 1
    MedDRA: Fatigue — Feeling: Fair
    Free text: Fatigue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-03-12
    Dose 2 — Moderna
  13. 2021-03-12
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to work
    Adult check-in
  14. 2021-03-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Arthralgia — Feeling: Poor · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to work
    Free text: Extreme shoulder pain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-03-14
    Survey response — days 1–6 daily, dose 2
    MedDRA: Arthralgia — Feeling: Poor · Site: Pain · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Extreme shoulder pain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-03-15
    Survey response — days 1–6 daily, dose 2
    MedDRA: Arthralgia — Feeling: Poor · Site: Pain · Be unable to work, Be unable to do your normal daily activities
    Free text: Extreme pain in shoulder
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-03-16
    Survey response — days 1–6 daily, dose 2
    MedDRA: Arthralgia — Feeling: Fair · Site: Pain · Be unable to do your normal daily activities
    Free text: Shoulder pain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-03-17
    Survey response — days 1–6 daily, dose 2
    MedDRA: Arthralgia — Feeling: Fair · Site: Pain · Be unable to do your normal daily activities
    Free text: Extreme shoulder pain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-03-18
    Survey response — days 1–6 daily, dose 2
    MedDRA: Arthralgia — Feeling: Fair · Site: Pain
    Free text: Shoulder pain in bursa
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-03-19
    Survey response — day 7, dose 2
    MedDRA: Arthralgia, Pain in extremity — Feeling: Fair · Site: Pain · Be unable to do your normal daily activities
    Free text: Shoulder and upper arm pain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-03-26
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  22. 2021-04-02
    Health check-in — day 21, dose 2
    Feeling: Fair
    Adult check-in
  23. 2021-04-09
    Health check-in — day 28, dose 2
    Feeling: Fair
    Adult check-in
  24. 2021-04-16
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  25. 2021-04-23
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  26. 2021-06-11
    Health check-in — 3 months, dose 2
    Feeling: Fair
    Adult check-in
  27. 2021-09-10
    Survey response — 6 months, dose 2
    MedDRA: Depression, Disturbance in attention, Fall, Impaired work ability, Memory impairment, Office visit, Parosmia, Taste disorder, Therapeutic response unexpected, Vertigo — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: Increased anxiety and depression. Increased vertigo and falls. Phantom smells. Changes in tastes of food and drink. Memory and concentration difficulty that interferes with work tasks. One interesting improvement - increased math skills. · Healthcare visit (other): Intensive outpatient treatment care for anxiety and depression.
    MedDRA releases: 2024-11 · check-in free text available
  28. 2021-09-10
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  29. 2021-09-15
  30. 2022-03-12
    Survey response — 12 months, dose 2
    MedDRA: Blood triglycerides increased, Hypertension, Office visit, Renal impairment — Feeling: Poor · Be unable to work or attend school, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Low renal function, high blood pressure, high triglycerides. · Healthcare visit (other): Doctors office, lab
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-03-12
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    1 call case(s)
  32. 2022-03-16

Vaccinations

DoseDateManufacturerCo-administered
12021-02-12Moderna
22021-03-12Moderna

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 5 — day 21, dose 1

2021-03-05

Symptoms: Fatigue

Release 5 — days 1–6 daily, dose 2

2021-03-13

Systemic reaction (other): Extreme shoulder pain

2021-03-14

Systemic reaction (other): Extreme shoulder pain

2021-03-15

Systemic reaction (other): Extreme pain in shoulder

2021-03-16

Systemic reaction (other): Shoulder pain

2021-03-17

Systemic reaction (other): Extreme shoulder pain

2021-03-18

Systemic reaction (other): Shoulder pain in bursa

Release 5 — day 7, dose 2

2021-03-19

Systemic reaction (other): Shoulder and upper arm pain

Release 9 — 6 months, dose 2

2021-09-10

Symptoms: Increased anxiety and depression. Increased vertigo and falls. Phantom smells. Changes in tastes of food and drink. Memory and concentration difficulty that interferes with work tasks. One interesting improvement - increased math skills.
Healthcare visit (other): Intensive outpatient treatment care for anxiety and depression.

Release 11 — 12 months, dose 2

2022-03-12

Symptoms: Low renal function, high blood pressure, high triglycerides.
Healthcare visit (other): Doctors office, lab

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVODepression · · ✓
HCVOOffice visit · · ✓
SDBlood triglycerides increased · · ✓
SDDepression · · ✓
SDDisturbance in attention · · ✓
SDFall · · ✓
SDFatigue ✓ ✓ ✓
SDHypertension · · ✓
SDImpaired work ability · · ✓
SDMemory impairment · · ✓
SDParosmia · · ✓
SDRenal impairment · · ✓
SDTaste disorder · · ✓
SDTherapeutic response unexpected · · ✓
SDVertigo · · ✓
SROArthralgia ✓ ✓ ✓
SROPain in extremity ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…